Recent Posts
- S1900N: A Randomized Phase II Study of Sacituzumab Govitecan Alone, Ivonescimab Alone, or Sacituzumab Govitecan and Ivonescimab in Participants with Previously-Treated Actionable Genomic Alteration Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Sub-study) (NCT # 07393555)
- PIKALO-2 (J6M-MC-JSGD)
- ResQ201A
- MM1MDS-A01: A Randomized Phase II Trial of Enasidenib-Based Therapies Versus Cedazuridine-Decitabine in Higher-Risk IDH2-Mutated Myelodysplastic Syndrome: A MyeloMATCH Sub-Study (NCT06577441)
- KRAScendo-2/CO45042
Recent Comments
No comments to show.


